Elan Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3167680002
JPY
702.00
35 (5.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 24.54%

  • Healthy long term growth as Net Sales has grown by an annual rate of 17.15% and Operating profit at 18.95%
  • Company has very low debt and has enough cash to service the debt requirements
2

Negative results in Jun 25

3

With ROE of 19.68%, it has a expensive valuation with a 4.05 Price to Book Value

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 42,784 Million (Small Cap)

stock-summary
P/E

21.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.32

stock-summary
Return on Equity

19.02%

stock-summary
Price to Book

3.16

Revenue and Profits:
Net Sales:
13,899 Million
(Quarterly Results - Sep 2025)
Net Profit:
669 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.95%
0%
-8.95%
6 Months
-16.33%
0%
-16.33%
1 Year
-5.14%
0%
-5.14%
2 Years
-34.21%
0%
-34.21%
3 Years
-29.31%
0%
-29.31%
4 Years
-31.98%
0%
-31.98%
5 Years
-54.09%
0%
-54.09%

Elan Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
17.15%
EBIT Growth (5y)
18.95%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.37
Sales to Capital Employed (avg)
3.85
Tax Ratio
33.49%
Dividend Payout Ratio
33.38%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
83.83%
ROE (avg)
24.54%

Valuation key factors

Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
4.05
EV to EBIT
12.26
EV to EBITDA
9.35
EV to Capital Employed
5.83
EV to Sales
0.92
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
47.58%
ROE (Latest)
19.68%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 15.80% vs 12.75% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 31.92% vs -20.22% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "13,898.80",
          "val2": "12,002.80",
          "chgp": "15.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,314.80",
          "val2": "1,049.20",
          "chgp": "25.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.90",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.50",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "668.70",
          "val2": "506.90",
          "chgp": "31.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "69.50%",
          "val2": "67.20%",
          "chgp": "0.23%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 14.70% vs 14.23% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -6.51% vs 20.93% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "47,513.70",
          "val2": "41,425.50",
          "chgp": "14.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,509.80",
          "val2": "3,853.10",
          "chgp": "17.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-8.40",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,354.70",
          "val2": "2,518.70",
          "chgp": "-6.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "75.60%",
          "val2": "88.50%",
          "chgp": "-1.29%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
13,898.80
12,002.80
15.80%
Operating Profit (PBDIT) excl Other Income
1,314.80
1,049.20
25.31%
Interest
13.90
0.00
Exceptional Items
3.50
0.00
Consolidate Net Profit
668.70
506.90
31.92%
Operating Profit Margin (Excl OI)
69.50%
67.20%
0.23%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 15.80% vs 12.75% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 31.92% vs -20.22% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
47,513.70
41,425.50
14.70%
Operating Profit (PBDIT) excl Other Income
4,509.80
3,853.10
17.04%
Interest
1.70
0.00
Exceptional Items
0.00
-8.40
100.00%
Consolidate Net Profit
2,354.70
2,518.70
-6.51%
Operating Profit Margin (Excl OI)
75.60%
88.50%
-1.29%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 14.70% vs 14.23% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -6.51% vs 20.93% in Dec 2023

stock-summaryCompany CV
About Elan Corp. stock-summary
stock-summary
Elan Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available